A vision of hope
You don’t know what it is to be an advocate until you are one.
That was never more clear to Harry and Gail Koujaian than when their 5-year-old daughter, Hayley, began having difficulty with motor function, verbal communication, and sight words. Then she had her first seizure.
It took six years of patient advocacy—challenging inaccurate diagnoses, meeting with doctors, pushing for medical tests, becoming “parent scientists,” scheduling surgeries, and planning regular therapy sessions—before the Koujaians would get the correct diagnosis: Niemann-Pick disease type C.
Niemann-Pick disease type C, or NPC, is an inherited, progressive genetic disorder caused by the body’s inability to transport cholesterol and other fatty substances inside of cells. The result is an irreversible dementia-like disease that affects a child’s ability to walk, talk, swallow, and think. The disorder is very rare, affecting one in 120,000 people, and death typically occurs before or during adolescence.
Hayley was diagnosed with the terminal disorder at the age of 11. Her older brother, Alec, was diagnosed shortly thereafter at 13.
The Koujaian family’s experience is all too common. With more than 7,000 different diseases classified as “rare,” 10 percent of the population is likely to encounter a diagnostic odyssey of unnecessary tests and wrong diagnoses in their push for effective care.
Originally published by news.nd.edu on February 29, 2024.
atLatest Research
- Conexus Indiana names Industry Labs’ Jody Suryatna to Rising 30 Class of 2024South Bend, IN(May 10, 2024) Industry Labs’ enfocus Project Manager, Jody Suryatna, has been named to the Rising 30 Class of 2024 for his work in advanced manufacturing and logistics (AML). Conexus Indiana today announced the…
- Students research and create a digital exhibition of art that speaks for democracy and human rightsThe Nanovic Institute for European Studies releases today its latest student-created digital exhibition called “Fighting for Democracy and Human Rights Through the Arts,” the culmination of the…
- "Learn every day." Rev. John I. Jenkins, C.S.C., reflects on 19 years as presidentIn October, it was announced that Rev. John I. Jenkins, C.S.C., would step down from his role as the 17th president of the University of Notre Dame. He has shaped and grown the University and its impact over the past 19 years in research, global engagement, and by attracting super faculty and the…
- Matthew Webber selected as director of Notre Dame’s Berthiaume Institute for Precision HealthMatthew J. Webber, the Keating-Crawford Collegiate Professor of Engineering and associate professor of chemical and biomolecular engineering at the University of Notre Dame, has been selected to serve as the acting director of the …
- As humans change the globe, they also influence the transmission of diseases, an extensive study in Nature showsHuman activity across the globe contributes to the rise in emerging infectious disease, but researchers had not concluded which of these activities, called global change drivers, increases risk the most. …
- Daniela Rovida receives Notre Dame Research grantDaniela Rovida, rare books cataloger and metadata librarian at the Hesburgh Libraries, was recently awarded a Research and Scholarship Program — Initiation Grant through Notre Dame Research.